Financial News
All News about Can-Fite Biopharma Ltd ADR
![](https://edge-cdn.isdr.io/accesswire/Accesswire_256x256.png )
![](https://mms.businesswire.com/media/20240628278831/en/1567498/22/logo_-_sq_400x400_300dpi_%28002%29.jpg.jpg)
![](https://mms.businesswire.com/media/20240624268136/en/1567498/22/logo_-_sq_400x400_300dpi_%28002%29.jpg.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_3.png?width=1200&height=800&fit=crop)
Can Fite Biofarma: Q4 Earnings Insights
March 28, 2024
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_0.png?width=1200&height=800&fit=crop)
Recap: Can Fite Biofarma Q3 Earnings
November 30, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_1.jpeg?width=1200&height=800&fit=crop)
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2024/06/14/movers-image_24.jpeg?width=1200&height=800&fit=crop)
![](https://mms.businesswire.com/media/20240610723784/en/1567498/22/logo_-_sq_400x400_300dpi_%28002%29.jpg.jpg)
![](https://mms.businesswire.com/media/20240605024229/en/1567498/22/logo_-_sq_400x400_300dpi_%28002%29.jpg.jpg)
![](https://mms.businesswire.com/media/20240529561163/en/1567498/22/logo_-_sq_400x400_300dpi_%28002%29.jpg.jpg)
![](https://mms.businesswire.com/media/20240527479547/en/1567498/22/logo_-_sq_400x400_300dpi_%28002%29.jpg.jpg)
![](https://mms.businesswire.com/media/20240523651578/en/1567498/22/logo_-_sq_400x400_300dpi_%28002%29.jpg.jpg)
![](https://mms.businesswire.com/media/20240513153232/en/1567498/22/logo_-_sq_400x400_300dpi_%28002%29.jpg.jpg)
![](https://edge-cdn.isdr.io/accesswire/Accesswire_256x256.png )
![](https://mms.businesswire.com/media/20240509103593/en/1567498/22/logo_-_sq_400x400_300dpi_%28002%29.jpg.jpg)
![](https://mms.businesswire.com/media/20240506802750/en/1567498/22/logo_-_sq_400x400_300dpi_%28002%29.jpg.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_0.jpeg?width=1200&height=800&fit=crop)
Via Benzinga
![](https://mms.businesswire.com/media/20240425661063/en/1567498/22/logo_-_sq_400x400_300dpi_%28002%29.jpg.jpg)
![](https://mms.businesswire.com/media/20240415044511/en/2097948/22/Liver2.jpg)
![](https://mms.businesswire.com/media/20240403043294/en/1567498/22/logo_-_sq_400x400_300dpi_%28002%29.jpg.jpg)
![](https://investorplace.com/wp-content/uploads/2022/05/earnings-season-1600.png)
![](https://mms.businesswire.com/media/20240328586605/en/1567498/22/logo_-_sq_400x400_300dpi_%28002%29.jpg.jpg)
Can-Fite Reports 2023 Financial Results and Clinical Update
March 28, 2024
Via Business Wire
![](https://mms.businesswire.com/media/20240311582155/en/1567498/22/logo_-_sq_400x400_300dpi_%28002%29.jpg.jpg)
![](https://mms.businesswire.com/media/20240228950836/en/1567498/22/logo_-_sq_400x400_300dpi_%28002%29.jpg.jpg)
![](https://mms.businesswire.com/media/20240130659110/en/1567498/22/logo_-_sq_400x400_300dpi_%28002%29.jpg.jpg)
![](https://mms.businesswire.com/media/20240129306975/en/1567498/22/logo_-_sq_400x400_300dpi_%28002%29.jpg.jpg)
![](https://mms.businesswire.com/media/20231220739293/en/1567498/22/logo_-_sq_400x400_300dpi_%28002%29.jpg.jpg)
![](https://mms.businesswire.com/media/20231218865060/en/1567498/22/logo_-_sq_400x400_300dpi_%28002%29.jpg.jpg)
Can-Fite Received FDA Positive Response to Psoriasis Pediatric Plan
December 18, 2023
Via Business Wire
![](https://mms.businesswire.com/media/20231204860062/en/1567498/22/logo_-_sq_400x400_300dpi_%28002%29.jpg.jpg)
![](https://mms.businesswire.com/media/20231130873648/en/1567498/22/logo_-_sq_400x400_300dpi_%28002%29.jpg.jpg)
Via Business Wire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.